Nomenclature
CAS number: 866-84-2
2-Hydroxy-1,2,3-propanetricarboxylic acid tripotassium salt; tripotassium citrate.
C
6H
5K
3O
7; mol wt 306.39.
C 23.52%, H 1.64%, K 38.28%, O 36.55%.
K
3C
6H
5O
7.
Description and references
Manufacturing process: G. Kominek, US 3819696 (1974 to Jungbunzlauer). Effect on urinary chemistry and crystallization of stone
forming salts: K. Sakhaee et al., Kidney Int. 24, 348 (1983). Use in oral rehydration
solutions: M. R. Islam, Arch. Dis. Child. 60, 852 (1985). Clinical trial in nephrolithiasis:
C. Y. C. Pak et al., J. Urol. 134, 11 (1985); following shockwave lithotripsy: T.
Soygür et al., J. Endourol. 16, 149 (2002).
Derivative
Monohydrate.
Nomenclature
CAS number: 6100-05-6
K-CIT-V (V.E.T.); Urocit-K (Mission Pharmacal).
C
6H
5K
3O
7.H
2O; mol wt 324.41.
C 22.21%, H 2.17%, K 36.16%, O 39.45%.
Properties
White crystals, granules or powder; odorless with
cooling, salty taste. Loses its water at 180°. One gram dissolves
in 0.65 ml water; very slowly in 2.5 ml glycerol. Practically insol
in alcohol. The aq soln is alkaline to litmus; pH about 8.5.Use
In foods and beverages as buffering, sequestering
or emulsifying agent.
Therapeutic Category
Alkalinizing agent; antiurolithic.
Therapeutic Category (Veterinary)
Alkalinizing agent; antiurolithic.
Keywords
Alkalinizing Agent; Antiurolithic